- Home
- MREO vs BGT Comparison
MREO vs BGT Comparison
Compare MREO & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- BGT
- Stock Information
- Founded
- MREO 2015
- BGT 2004
- Country
- MREO United Kingdom
- BGT United States
- Employees
- MREO N/A
- BGT N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- BGT Trusts Except Educational Religious and Charitable
- Sector
- MREO Health Care
- BGT Finance
- Exchange
- MREO Nasdaq
- BGT Nasdaq
- Market Cap
- MREO 326.1M
- BGT 320.3M
- IPO Year
- MREO N/A
- BGT N/A
- Fundamental
- Price
- MREO $1.97
- BGT $12.16
- Analyst Decision
- MREO Strong Buy
- BGT
- Analyst Count
- MREO 5
- BGT 0
- Target Price
- MREO $7.40
- BGT N/A
- AVG Volume (30 Days)
- MREO 1.3M
- BGT 107.2K
- Earning Date
- MREO 11-11-2025
- BGT 01-01-0001
- Dividend Yield
- MREO N/A
- BGT 10.77%
- EPS Growth
- MREO N/A
- BGT N/A
- EPS
- MREO N/A
- BGT N/A
- Revenue
- MREO $500,000.00
- BGT N/A
- Revenue This Year
- MREO N/A
- BGT N/A
- Revenue Next Year
- MREO $72.16
- BGT N/A
- P/E Ratio
- MREO N/A
- BGT N/A
- Revenue Growth
- MREO N/A
- BGT N/A
- 52 Week Low
- MREO $1.47
- BGT $10.89
- 52 Week High
- MREO $4.72
- BGT $13.42
- Technical
- Relative Strength Index (RSI)
- MREO 57.79
- BGT 43.76
- Support Level
- MREO $1.94
- BGT $12.02
- Resistance Level
- MREO $2.12
- BGT $12.25
- Average True Range (ATR)
- MREO 0.11
- BGT 0.11
- MACD
- MREO 0.02
- BGT -0.01
- Stochastic Oscillator
- MREO 62.65
- BGT 33.36
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About BGT BlackRock Floating Rate Income Trust
Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.